162 related articles for article (PubMed ID: 32664162)
1. Effect of thyrotropin suppressive therapy on heart rate variability and QT dispersion in patients with differentiated thyroid cancer.
Liu C; Lv H; Li Q; Fu S; Tan J; Wang C; Wang X; Ma Y
Medicine (Baltimore); 2020 Jul; 99(28):e21190. PubMed ID: 32664162
[TBL] [Abstract][Full Text] [Related]
2. Heart rate variability and QT dispersion in patients with subclinical hypothyroidism.
Galetta F; Franzoni F; Fallahi P; Rossi M; Carpi A; Rubello D; Antonelli A; Santoro G
Biomed Pharmacother; 2006 Sep; 60(8):425-30. PubMed ID: 16930934
[TBL] [Abstract][Full Text] [Related]
3. Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer.
Casu M; Cappi C; Patrone V; Repetto E; Giusti M; Minuto F; Murialdo G
Eur J Endocrinol; 2005 Jun; 152(6):819-24. PubMed ID: 15941920
[TBL] [Abstract][Full Text] [Related]
4. Effects of recombinant human thyrotropin on heart rate variability and blood pressure in patients on l-thyroxine-suppressive therapy for differentiated thyroid carcinoma.
Murialdo G; Casu M; Cappi C; Patrone V; Repetto E; Copello F; Minuto F; Giusti M
Horm Res; 2005; 64(2):100-6. PubMed ID: 16179790
[TBL] [Abstract][Full Text] [Related]
5. Effects of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with thyroid cancer.
Mousavi Z; Dourandish L; Rokni H; Sadeghi R; Rasoul Zakavi S
Minerva Endocrinol; 2014 Mar; 39(1):59-65. PubMed ID: 24513605
[TBL] [Abstract][Full Text] [Related]
6. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
7. Effect of percutaneous transluminal coronary angioplasty on QT dispersion and heart rate variability parameters.
Aydinlar A; Sentürk T; Ozdemïr B; Kaderlï AA; Aydin O
Cardiovasc J Afr; 2009; 20(4):240-4. PubMed ID: 19701536
[TBL] [Abstract][Full Text] [Related]
8. Effects of carvedilol therapy on arrhythmia markers in patients with congestive heart failure.
Akdeniz B; Guneri S; Savas IZ; Aslan O; Baris N; Badak O; Kirimli O; Göldeli O
Int Heart J; 2006 Jul; 47(4):565-73. PubMed ID: 16960411
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
10. Changes in heart rate variability and QT dispersion in patients with overt hypothyroidism.
Galetta F; Franzoni F; Fallahi P; Tocchini L; Braccini L; Santoro G; Antonelli A
Eur J Endocrinol; 2008 Jan; 158(1):85-90. PubMed ID: 18166821
[TBL] [Abstract][Full Text] [Related]
11. Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok.
Thewjitcharoen Y; Chatchomchuan W; Wanothayaroj E; Butadej S; Nakasatien S; Krittiyawong S; Rajatanavin R; Himathongkam T
Medicine (Baltimore); 2024 May; 103(21):e38290. PubMed ID: 38788029
[TBL] [Abstract][Full Text] [Related]
12. Effects of Chronic Suppression or Oversuppression of Thyroid-Stimulating Hormone on Psychological Symptoms and Sleep Quality in Patients with Differentiated Thyroid Cancer.
Altuntaş SÇ; Hocaoğlu Ç
Horm Metab Res; 2021 Oct; 53(10):683-691. PubMed ID: 34607367
[TBL] [Abstract][Full Text] [Related]
13. Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy.
Verburg FA; Smit JW; Grelle I; Visser TJ; Peeters RP; Reiners C
Clin Endocrinol (Oxf); 2012 Apr; 76(4):577-81. PubMed ID: 22017394
[TBL] [Abstract][Full Text] [Related]
14. [L-thyroxine therapy in differentiated thyroid carcinoma: criteria for evaluation of TSH suppression].
Kowalczyk P; Roskosz J; Jurecka-Tuleja B; Gubała E; Czernik E; Jarzab B
Wiad Lek; 2001; 54(5-6):268-76. PubMed ID: 11556209
[TBL] [Abstract][Full Text] [Related]
15. Imbalance of cardiac autonomic nervous activity and increase of ventricular repolarization dynamicity induced by thyroid hormones in hyperthyroidism.
Cai Z; Dai M; Zhang Y; Zhong H; Tan T; Bao M
Auton Neurosci; 2018 Sep; 213():86-91. PubMed ID: 30005745
[TBL] [Abstract][Full Text] [Related]
16. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
[No Abstract] [Full Text] [Related]
17. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
[TBL] [Abstract][Full Text] [Related]
18. [Research of relationship between thyroid-stimulating hormone level after surgery and hypercholesterolemia in female patients with differentiated thyroid cancer].
Zhang B; Geng L; Lin H; Jia Q; Li T
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 34(6):554-557. PubMed ID: 32842190
[No Abstract] [Full Text] [Related]
19. Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy.
Liewendahl K; Helenius T; Lamberg BA; Mähönen H; Wägar G
Acta Endocrinol (Copenh); 1987 Nov; 116(3):418-24. PubMed ID: 3687325
[TBL] [Abstract][Full Text] [Related]
20. Effects of thyroid hormone replacement therapy on thyroid hormone levels and electrocardiogram changes in geriatric patients with hypothyroidism.
Zhai X
Pak J Pharm Sci; 2017 Sep; 30(5(Supplementary)):1939-1942. PubMed ID: 29105624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
